Americans overspend $73bn on branded drugs
File this under ‘unintended consequences.’ A number of health care organizations are complaining that a final guideline the US Food […]
Mark Cuban Sounds Off on Drug Prices
By Dylan Scott, Posted with permission from STAT Mark Cuban has something to say about prescription drug prices. The billionaire
Some biosimilars are just as good as some pricey biologics
Some Biosimilars Are Just as Good as Some Pricey Biologics: A Game-Changer in Healthcare In the world of medicine, we’re
Some biosimilars are just as good as some pricey biologics Read Post »
Guest Content
DrugPatentWatch Guest Article Agreement
Thank you for your interest in submitting a guest article! Submit your guest article here DrugPatentWatch is interested in sharing
Drug Repositioning in the Mirror of Patenting: Surveying and Mining Uncharted Territory
Hermann A. M. Mucke*, H. M. Pharma Consultancy, Wien, Austria A Multimodal Approach to the Re-development of Drugs Drug repositioning—the
Drug Repositioning in the Mirror of Patenting: Surveying and Mining Uncharted Territory Read Post »
Publish With DrugPatentWatch
Share your expertise with our expansive network > Go to submission form < Do you want to reach a large
